Blueprint Medicines Investigative Scientist Award in Mastocytosis
Forecasted
This award supports early-career researchers conducting innovative basic or translational research in mastocytosis within dermatology or cutaneous biology.
Funder: American Skin Association
Due Dates (Anticipated): June 2027 (Full application deadline, projected)
Funding Amounts: $100,000 total; 1-year award; no indirect costs, salary, or travel allowed
Summary: Supports early-career researchers advancing innovative basic or translational research in mastocytosis within dermatology or cutaneous biology.
Key Information: Preference for applicants under 45 and with limited prior major research funding.
Description
This award, offered by the American Skin Association (ASA) and sponsored by Blueprint Medicines, is designed to support early-career investigators conducting innovative research on mastocytosis within dermatology or cutaneous biology. The intent is to provide bridge funding to young scientists (instructor through associate professor level) who are committed to advancing the understanding or treatment of mastocytosis through basic or translational research. The program particularly encourages applications from those with limited prior support and aims to foster the next generation of leaders in dermatological investigation.
